Fujimura S, Sakurada A, Sagawa M, Saito Y, Takahashi H, Tanita T, Ono S, Matsumura S, Kondo T, Sato M
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Cancer. 2000 Dec 1;89(11 Suppl):2445-8. doi: 10.1002/1097-0142(20001201)89:11+<2445::aid-cncr19>3.3.co;2-m.
The significance of limited resections, including wedge resection and segmentectomy, remains controversial because of their curability rates. In the current study, the objective was to determine a strategy for the treatment of patients with roentgenographically occult bronchogenic squamous cell carcinoma (ROSCC) based on the pathologic findings from 184 patients with ROSCC who underwent resection.
In Miyagi Prefecture, 1422 patients with lung carcinoma were diagnosed during a mass screening program between 1982 and 1995. Among them, 236 patients had ROSCC, and 184 patients with ROSCC underwent pulmonary resection followed by systemic lymph node dissection.
Pathologically, only 0.9% of the ROSCCs that were within the range of endoscopic visibility were revealed to have lymph node involvement, whereas 13% of patients with extracartilage invasion had lymph node involvement. Early ROSCC, which means ROSCC that is limited within the cartilaginous layer and is without lymph node involvement, comprised 90% of ROSCCs that measured <10 mm in longitudinal extension, comprised 77% of ROSCCs that measured 10-29 mm in longitudinal extension, and comprised 33% of ROSCCs that measured >30 mm in longitudinal extension. Eighty-nine percent of the tumors with lymph node involvement had extracartilaginous invasion. The 3-year survival rate of patients after undergoing photodynamic therapy was 100% when their tumor was regarded as early ROSCC (i.e., within 10 mm in longitudinal extension and within the range of endoscopic visibility). To date, 18 patients with ROSCC underwent segmentectomy, and all of these patients are alive without tumor recurrence. The incidence rate of multiple lung carcinomas, including synchronous and metachronous tumors, in patients with ROSCC was 22%.
The authors concluded the following: 1) Patients with lesions that are within the range of endoscopic visibility and that measure <10 mm in longitudinal extension are candidates for photodynamic therapy. 2) Patients with lesions that are beyond the range of endoscopic visibility or that measure >10 mm in longitudinal extension are candidates for segmentectomy as long as intraoperative examination shows a tumor free bronchial stump and negative lymph nodes 11-13. 3) Patients with lesions that show bronchial obstruction or extrabronchial invasion should undergo standard resection.
包括楔形切除术和肺段切除术在内的局限性切除术的意义,因其治愈率而仍存在争议。在本研究中,目的是基于184例接受切除术的隐匿性支气管源性鳞状细胞癌(ROSCC)患者的病理结果,确定ROSCC患者的治疗策略。
在宫城县,1982年至1995年的大规模筛查项目期间诊断出1422例肺癌患者。其中,236例患有ROSCC,184例ROSCC患者接受了肺切除及系统性淋巴结清扫术。
病理上,内镜可见范围内的ROSCC中只有0.9%显示有淋巴结受累,而软骨外侵犯的患者中有13%有淋巴结受累。早期ROSCC,即局限于软骨层内且无淋巴结受累的ROSCC,在纵向延伸<10 mm的ROSCC中占90%,在纵向延伸10 - 29 mm的ROSCC中占77%,在纵向延伸>30 mm的ROSCC中占33%。有淋巴结受累的肿瘤中89%有软骨外侵犯。当肿瘤被视为早期ROSCC(即纵向延伸在10 mm以内且在内镜可见范围内)时,接受光动力治疗的患者3年生存率为100%。迄今为止,18例ROSCC患者接受了肺段切除术,所有这些患者均存活且无肿瘤复发。ROSCC患者中包括同时性和异时性肿瘤在内的多原发性肺癌的发生率为22%。
作者得出以下结论:1)内镜可见范围内且纵向延伸<10 mm的病变患者适合光动力治疗。2)内镜可见范围以外或纵向延伸>10 mm的病变患者,只要术中检查显示支气管残端无肿瘤且淋巴结阴性(11 - 13组),适合肺段切除术。3)显示支气管阻塞或支气管外侵犯的病变患者应接受标准切除术。